nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PTGS2—glaucoma	0.455	1	CbGaD
Mesalazine—Salicylate-sodium—PTGS2—glaucoma	0.00103	0.3	CrCbGaD
Mesalazine—MPO—endothelium—glaucoma	0.000771	0.157	CbGeAlD
Mesalazine—CHUK—connective tissue—glaucoma	0.000765	0.156	CbGeAlD
Mesalazine—Olsalazine—PTGS2—glaucoma	0.000703	0.206	CrCbGaD
Mesalazine—PPARG—endothelium—glaucoma	0.000684	0.139	CbGeAlD
Mesalazine—Diflunisal—PTGS2—glaucoma	0.000661	0.193	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—glaucoma	0.000661	0.193	CrCbGaD
Mesalazine—IKBKB—connective tissue—glaucoma	0.00052	0.106	CbGeAlD
Mesalazine—ALOX5—connective tissue—glaucoma	0.000431	0.0877	CbGeAlD
Mesalazine—Salicylic acid—PTGS2—glaucoma	0.000368	0.108	CrCbGaD
Mesalazine—PTGS1—endothelium—glaucoma	0.000366	0.0745	CbGeAlD
Mesalazine—MPO—connective tissue—glaucoma	0.000364	0.0742	CbGeAlD
Mesalazine—PTGS2—endothelium—glaucoma	0.00035	0.0712	CbGeAlD
Mesalazine—PPARG—connective tissue—glaucoma	0.000323	0.0659	CbGeAlD
Mesalazine—PTGS1—connective tissue—glaucoma	0.000173	0.0352	CbGeAlD
Mesalazine—PTGS2—connective tissue—glaucoma	0.000165	0.0337	CbGeAlD
Mesalazine—Gastrointestinal pain—Dorzolamide—glaucoma	0.00015	0.000403	CcSEcCtD
Mesalazine—Alopecia—Betaxolol—glaucoma	0.00015	0.000403	CcSEcCtD
Mesalazine—Palpitations—Clonidine—glaucoma	0.00015	0.000403	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00015	0.000402	CcSEcCtD
Mesalazine—Gastrointestinal pain—Travoprost—glaucoma	0.000149	0.000401	CcSEcCtD
Mesalazine—Loss of consciousness—Clonidine—glaucoma	0.000149	0.0004	CcSEcCtD
Mesalazine—Feeling abnormal—Brinzolamide—glaucoma	0.000149	0.000399	CcSEcCtD
Mesalazine—Mental disorder—Betaxolol—glaucoma	0.000149	0.000399	CcSEcCtD
Mesalazine—Constipation—Pilocarpine—glaucoma	0.000148	0.000398	CcSEcCtD
Mesalazine—Pain—Pilocarpine—glaucoma	0.000148	0.000398	CcSEcCtD
Mesalazine—Cough—Clonidine—glaucoma	0.000148	0.000398	CcSEcCtD
Mesalazine—Sweating—Timolol—glaucoma	0.000148	0.000398	CcSEcCtD
Mesalazine—Dizziness—Apraclonidine—glaucoma	0.000148	0.000397	CcSEcCtD
Mesalazine—Erythema—Betaxolol—glaucoma	0.000148	0.000397	CcSEcCtD
Mesalazine—Urticaria—Dorzolamide—glaucoma	0.000146	0.000391	CcSEcCtD
Mesalazine—Epistaxis—Timolol—glaucoma	0.000146	0.000391	CcSEcCtD
Mesalazine—Body temperature increased—Dorzolamide—glaucoma	0.000145	0.00039	CcSEcCtD
Mesalazine—Abdominal pain—Dorzolamide—glaucoma	0.000145	0.00039	CcSEcCtD
Mesalazine—Tension—Betaxolol—glaucoma	0.000145	0.000389	CcSEcCtD
Mesalazine—Sinusitis—Timolol—glaucoma	0.000145	0.000389	CcSEcCtD
Mesalazine—Dysgeusia—Betaxolol—glaucoma	0.000145	0.000388	CcSEcCtD
Mesalazine—Arthralgia—Clonidine—glaucoma	0.000144	0.000388	CcSEcCtD
Mesalazine—Chest pain—Clonidine—glaucoma	0.000144	0.000388	CcSEcCtD
Mesalazine—Abdominal pain—Travoprost—glaucoma	0.000144	0.000388	CcSEcCtD
Mesalazine—Agranulocytosis—Timolol—glaucoma	0.000144	0.000387	CcSEcCtD
Mesalazine—Anxiety—Clonidine—glaucoma	0.000144	0.000387	CcSEcCtD
Mesalazine—Asthenia—Acetazolamide—glaucoma	0.000144	0.000386	CcSEcCtD
Mesalazine—Dizziness—Bimatoprost—glaucoma	0.000143	0.000385	CcSEcCtD
Mesalazine—Nervousness—Betaxolol—glaucoma	0.000143	0.000385	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000143	0.000385	CcSEcCtD
Mesalazine—Urticaria—Brinzolamide—glaucoma	0.000143	0.000385	CcSEcCtD
Mesalazine—Feeling abnormal—Pilocarpine—glaucoma	0.000143	0.000384	CcSEcCtD
Mesalazine—Discomfort—Clonidine—glaucoma	0.000143	0.000383	CcSEcCtD
Mesalazine—Vomiting—Apraclonidine—glaucoma	0.000142	0.000382	CcSEcCtD
Mesalazine—Muscle spasms—Betaxolol—glaucoma	0.000142	0.000381	CcSEcCtD
Mesalazine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000142	0.000381	CcSEcCtD
Mesalazine—Hypersensitivity—Brimonidine—glaucoma	0.000141	0.00038	CcSEcCtD
Mesalazine—Dry mouth—Clonidine—glaucoma	0.000141	0.000379	CcSEcCtD
Mesalazine—Dermatitis—Apraclonidine—glaucoma	0.000141	0.000379	CcSEcCtD
Mesalazine—Headache—Apraclonidine—glaucoma	0.00014	0.000377	CcSEcCtD
Mesalazine—Confusional state—Clonidine—glaucoma	0.00014	0.000375	CcSEcCtD
Mesalazine—Vision blurred—Betaxolol—glaucoma	0.000139	0.000374	CcSEcCtD
Mesalazine—Rhinitis—Timolol—glaucoma	0.000139	0.000373	CcSEcCtD
Mesalazine—Oedema—Clonidine—glaucoma	0.000138	0.000372	CcSEcCtD
Mesalazine—Tremor—Betaxolol—glaucoma	0.000138	0.000372	CcSEcCtD
Mesalazine—Asthenia—Brimonidine—glaucoma	0.000138	0.00037	CcSEcCtD
Mesalazine—Infection—Clonidine—glaucoma	0.000137	0.000369	CcSEcCtD
Mesalazine—Abdominal pain—Pilocarpine—glaucoma	0.000137	0.000368	CcSEcCtD
Mesalazine—Body temperature increased—Pilocarpine—glaucoma	0.000137	0.000368	CcSEcCtD
Mesalazine—Ill-defined disorder—Betaxolol—glaucoma	0.000137	0.000368	CcSEcCtD
Mesalazine—Diarrhoea—Acetazolamide—glaucoma	0.000137	0.000368	CcSEcCtD
Mesalazine—Rash—Bimatoprost—glaucoma	0.000137	0.000367	CcSEcCtD
Mesalazine—Dermatitis—Bimatoprost—glaucoma	0.000137	0.000367	CcSEcCtD
Mesalazine—Oedema peripheral—Timolol—glaucoma	0.000136	0.000367	CcSEcCtD
Mesalazine—Anaemia—Betaxolol—glaucoma	0.000136	0.000367	CcSEcCtD
Mesalazine—Shock—Clonidine—glaucoma	0.000136	0.000366	CcSEcCtD
Mesalazine—Connective tissue disorder—Timolol—glaucoma	0.000136	0.000366	CcSEcCtD
Mesalazine—Pruritus—Brimonidine—glaucoma	0.000136	0.000365	CcSEcCtD
Mesalazine—Headache—Bimatoprost—glaucoma	0.000136	0.000365	CcSEcCtD
Mesalazine—Nervous system disorder—Clonidine—glaucoma	0.000136	0.000365	CcSEcCtD
Mesalazine—Thrombocytopenia—Clonidine—glaucoma	0.000135	0.000364	CcSEcCtD
Mesalazine—Hypersensitivity—Dorzolamide—glaucoma	0.000135	0.000363	CcSEcCtD
Mesalazine—Tachycardia—Clonidine—glaucoma	0.000135	0.000363	CcSEcCtD
Mesalazine—Hypersensitivity—Travoprost—glaucoma	0.000135	0.000361	CcSEcCtD
Mesalazine—Skin disorder—Clonidine—glaucoma	0.000134	0.000361	CcSEcCtD
Mesalazine—Hyperhidrosis—Clonidine—glaucoma	0.000134	0.000359	CcSEcCtD
Mesalazine—Malaise—Betaxolol—glaucoma	0.000133	0.000358	CcSEcCtD
Mesalazine—Nausea—Apraclonidine—glaucoma	0.000133	0.000357	CcSEcCtD
Mesalazine—Hypersensitivity—Brinzolamide—glaucoma	0.000133	0.000357	CcSEcCtD
Mesalazine—Vertigo—Betaxolol—glaucoma	0.000133	0.000356	CcSEcCtD
Mesalazine—Syncope—Betaxolol—glaucoma	0.000132	0.000356	CcSEcCtD
Mesalazine—Dizziness—Acetazolamide—glaucoma	0.000132	0.000356	CcSEcCtD
Mesalazine—Anorexia—Clonidine—glaucoma	0.000132	0.000354	CcSEcCtD
Mesalazine—Asthenia—Dorzolamide—glaucoma	0.000132	0.000354	CcSEcCtD
Mesalazine—Asthenia—Travoprost—glaucoma	0.000131	0.000352	CcSEcCtD
Mesalazine—Palpitations—Betaxolol—glaucoma	0.00013	0.000351	CcSEcCtD
Mesalazine—Pruritus—Dorzolamide—glaucoma	0.00013	0.000349	CcSEcCtD
Mesalazine—Loss of consciousness—Betaxolol—glaucoma	0.00013	0.000349	CcSEcCtD
Mesalazine—Eye disorder—Timolol—glaucoma	0.000129	0.000348	CcSEcCtD
Mesalazine—Asthenia—Brinzolamide—glaucoma	0.000129	0.000348	CcSEcCtD
Mesalazine—Hypotension—Clonidine—glaucoma	0.000129	0.000347	CcSEcCtD
Mesalazine—Pruritus—Travoprost—glaucoma	0.000129	0.000347	CcSEcCtD
Mesalazine—Tinnitus—Timolol—glaucoma	0.000129	0.000347	CcSEcCtD
Mesalazine—Cough—Betaxolol—glaucoma	0.000129	0.000346	CcSEcCtD
Mesalazine—Nausea—Bimatoprost—glaucoma	0.000129	0.000346	CcSEcCtD
Mesalazine—Cardiac disorder—Timolol—glaucoma	0.000129	0.000345	CcSEcCtD
Mesalazine—Hypersensitivity—Pilocarpine—glaucoma	0.000128	0.000343	CcSEcCtD
Mesalazine—Pruritus—Brinzolamide—glaucoma	0.000128	0.000343	CcSEcCtD
Mesalazine—Vomiting—Acetazolamide—glaucoma	0.000127	0.000342	CcSEcCtD
Mesalazine—Dizziness—Brimonidine—glaucoma	0.000127	0.000341	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000126	0.000339	CcSEcCtD
Mesalazine—Angiopathy—Timolol—glaucoma	0.000126	0.000338	CcSEcCtD
Mesalazine—Arthralgia—Betaxolol—glaucoma	0.000126	0.000338	CcSEcCtD
Mesalazine—Chest pain—Betaxolol—glaucoma	0.000126	0.000338	CcSEcCtD
Mesalazine—Myalgia—Betaxolol—glaucoma	0.000126	0.000338	CcSEcCtD
Mesalazine—Diarrhoea—Dorzolamide—glaucoma	0.000125	0.000337	CcSEcCtD
Mesalazine—Headache—Acetazolamide—glaucoma	0.000125	0.000337	CcSEcCtD
Mesalazine—Anxiety—Betaxolol—glaucoma	0.000125	0.000337	CcSEcCtD
Mesalazine—Insomnia—Clonidine—glaucoma	0.000125	0.000336	CcSEcCtD
Mesalazine—Immune system disorder—Timolol—glaucoma	0.000125	0.000336	CcSEcCtD
Mesalazine—Diarrhoea—Travoprost—glaucoma	0.000125	0.000336	CcSEcCtD
Mesalazine—Mediastinal disorder—Timolol—glaucoma	0.000125	0.000335	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000125	0.000335	CcSEcCtD
Mesalazine—Asthenia—Pilocarpine—glaucoma	0.000124	0.000334	CcSEcCtD
Mesalazine—Paraesthesia—Clonidine—glaucoma	0.000124	0.000334	CcSEcCtD
Mesalazine—Discomfort—Betaxolol—glaucoma	0.000124	0.000334	CcSEcCtD
Mesalazine—Dyspnoea—Clonidine—glaucoma	0.000123	0.000332	CcSEcCtD
Mesalazine—Diarrhoea—Brinzolamide—glaucoma	0.000123	0.000331	CcSEcCtD
Mesalazine—Somnolence—Clonidine—glaucoma	0.000123	0.000331	CcSEcCtD
Mesalazine—Dry mouth—Betaxolol—glaucoma	0.000123	0.00033	CcSEcCtD
Mesalazine—Pruritus—Pilocarpine—glaucoma	0.000123	0.000329	CcSEcCtD
Mesalazine—Alopecia—Timolol—glaucoma	0.000122	0.000329	CcSEcCtD
Mesalazine—Confusional state—Betaxolol—glaucoma	0.000121	0.000326	CcSEcCtD
Mesalazine—Mental disorder—Timolol—glaucoma	0.000121	0.000326	CcSEcCtD
Mesalazine—Dizziness—Dorzolamide—glaucoma	0.000121	0.000326	CcSEcCtD
Mesalazine—Rash—Brimonidine—glaucoma	0.000121	0.000325	CcSEcCtD
Mesalazine—Dermatitis—Brimonidine—glaucoma	0.000121	0.000325	CcSEcCtD
Mesalazine—Dizziness—Travoprost—glaucoma	0.000121	0.000324	CcSEcCtD
Mesalazine—Erythema—Timolol—glaucoma	0.000121	0.000324	CcSEcCtD
Mesalazine—Oedema—Betaxolol—glaucoma	0.00012	0.000324	CcSEcCtD
Mesalazine—Headache—Brimonidine—glaucoma	0.00012	0.000323	CcSEcCtD
Mesalazine—Decreased appetite—Clonidine—glaucoma	0.00012	0.000323	CcSEcCtD
Mesalazine—Infection—Betaxolol—glaucoma	0.00012	0.000322	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Clonidine—glaucoma	0.000119	0.000321	CcSEcCtD
Mesalazine—Fatigue—Clonidine—glaucoma	0.000119	0.000321	CcSEcCtD
Mesalazine—Dizziness—Brinzolamide—glaucoma	0.000119	0.00032	CcSEcCtD
Mesalazine—CHUK—Immune System—CTSA—glaucoma	0.000119	0.000722	CbGpPWpGaD
Mesalazine—Nausea—Acetazolamide—glaucoma	0.000119	0.000319	CcSEcCtD
Mesalazine—Diarrhoea—Pilocarpine—glaucoma	0.000119	0.000319	CcSEcCtD
Mesalazine—Shock—Betaxolol—glaucoma	0.000119	0.000318	CcSEcCtD
Mesalazine—Tension—Timolol—glaucoma	0.000118	0.000318	CcSEcCtD
Mesalazine—Pain—Clonidine—glaucoma	0.000118	0.000318	CcSEcCtD
Mesalazine—Constipation—Clonidine—glaucoma	0.000118	0.000318	CcSEcCtD
Mesalazine—Nervous system disorder—Betaxolol—glaucoma	0.000118	0.000317	CcSEcCtD
Mesalazine—Dysgeusia—Timolol—glaucoma	0.000118	0.000317	CcSEcCtD
Mesalazine—Thrombocytopenia—Betaxolol—glaucoma	0.000118	0.000317	CcSEcCtD
Mesalazine—Tachycardia—Betaxolol—glaucoma	0.000118	0.000316	CcSEcCtD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000117	0.000712	CbGpPWpGaD
Mesalazine—Nervousness—Timolol—glaucoma	0.000117	0.000315	CcSEcCtD
Mesalazine—Skin disorder—Betaxolol—glaucoma	0.000117	0.000314	CcSEcCtD
Mesalazine—Vomiting—Dorzolamide—glaucoma	0.000117	0.000313	CcSEcCtD
Mesalazine—Hyperhidrosis—Betaxolol—glaucoma	0.000116	0.000313	CcSEcCtD
Mesalazine—Rash—Dorzolamide—glaucoma	0.000116	0.000311	CcSEcCtD
Mesalazine—Dermatitis—Dorzolamide—glaucoma	0.000116	0.00031	CcSEcCtD
Mesalazine—PTGS2—Metabolism—NARFL—glaucoma	0.000115	0.000699	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CA5A—glaucoma	0.000115	0.000699	CbGpPWpGaD
Mesalazine—Rash—Travoprost—glaucoma	0.000115	0.000309	CcSEcCtD
Mesalazine—Dermatitis—Travoprost—glaucoma	0.000115	0.000309	CcSEcCtD
Mesalazine—Headache—Dorzolamide—glaucoma	0.000115	0.000309	CcSEcCtD
Mesalazine—Anorexia—Betaxolol—glaucoma	0.000115	0.000309	CcSEcCtD
Mesalazine—Vomiting—Brinzolamide—glaucoma	0.000115	0.000308	CcSEcCtD
Mesalazine—Dizziness—Pilocarpine—glaucoma	0.000115	0.000308	CcSEcCtD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000114	0.000694	CbGpPWpGaD
Mesalazine—Headache—Travoprost—glaucoma	0.000114	0.000307	CcSEcCtD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—glaucoma	0.000114	0.000693	CbGpPWpGaD
Mesalazine—Nausea—Brimonidine—glaucoma	0.000114	0.000306	CcSEcCtD
Mesalazine—Feeling abnormal—Clonidine—glaucoma	0.000114	0.000306	CcSEcCtD
Mesalazine—Rash—Brinzolamide—glaucoma	0.000114	0.000305	CcSEcCtD
Mesalazine—Vision blurred—Timolol—glaucoma	0.000114	0.000305	CcSEcCtD
Mesalazine—Dermatitis—Brinzolamide—glaucoma	0.000114	0.000305	CcSEcCtD
Mesalazine—CHUK—Disease—FGFR1OP—glaucoma	0.000113	0.000688	CbGpPWpGaD
Mesalazine—CHUK—Disease—HEYL—glaucoma	0.000113	0.000688	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Clonidine—glaucoma	0.000113	0.000304	CcSEcCtD
Mesalazine—Headache—Brinzolamide—glaucoma	0.000113	0.000303	CcSEcCtD
Mesalazine—Hypotension—Betaxolol—glaucoma	0.000113	0.000303	CcSEcCtD
Mesalazine—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	0.000112	0.000679	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LRP12—glaucoma	0.000112	0.000678	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—TP53—glaucoma	0.000112	0.000677	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—BAD—glaucoma	0.000111	0.000674	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—TNF—glaucoma	0.000111	0.000673	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000111	0.000671	CbGpPWpGaD
Mesalazine—Angioedema—Timolol—glaucoma	0.00011	0.000296	CcSEcCtD
Mesalazine—Vomiting—Pilocarpine—glaucoma	0.00011	0.000296	CcSEcCtD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00011	0.000668	CbGpPWpGaD
Mesalazine—Urticaria—Clonidine—glaucoma	0.00011	0.000295	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00011	0.000295	CcSEcCtD
Mesalazine—CHUK—Signaling by NGF—NGF—glaucoma	0.000109	0.000664	CbGpPWpGaD
Mesalazine—Abdominal pain—Clonidine—glaucoma	0.000109	0.000294	CcSEcCtD
Mesalazine—Body temperature increased—Clonidine—glaucoma	0.000109	0.000294	CcSEcCtD
Mesalazine—Rash—Pilocarpine—glaucoma	0.000109	0.000294	CcSEcCtD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000109	0.000662	CbGpPWpGaD
Mesalazine—Dermatitis—Pilocarpine—glaucoma	0.000109	0.000293	CcSEcCtD
Mesalazine—Insomnia—Betaxolol—glaucoma	0.000109	0.000293	CcSEcCtD
Mesalazine—Nausea—Dorzolamide—glaucoma	0.000109	0.000293	CcSEcCtD
Mesalazine—Headache—Pilocarpine—glaucoma	0.000109	0.000292	CcSEcCtD
Mesalazine—Nausea—Travoprost—glaucoma	0.000108	0.000291	CcSEcCtD
Mesalazine—Vertigo—Timolol—glaucoma	0.000108	0.000291	CcSEcCtD
Mesalazine—IKBKB—Apoptosis—TNF—glaucoma	0.000108	0.000656	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.000108	0.000656	CbGpPWpGaD
Mesalazine—Paraesthesia—Betaxolol—glaucoma	0.000108	0.000291	CcSEcCtD
Mesalazine—Syncope—Timolol—glaucoma	0.000108	0.000291	CcSEcCtD
Mesalazine—IKBKB—Immune System—CTSA—glaucoma	0.000108	0.000654	CbGpPWpGaD
Mesalazine—Dyspnoea—Betaxolol—glaucoma	0.000107	0.000289	CcSEcCtD
Mesalazine—Nausea—Brinzolamide—glaucoma	0.000107	0.000288	CcSEcCtD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000107	0.000649	CbGpPWpGaD
Mesalazine—Palpitations—Timolol—glaucoma	0.000107	0.000286	CcSEcCtD
Mesalazine—Dyspepsia—Betaxolol—glaucoma	0.000106	0.000285	CcSEcCtD
Mesalazine—Loss of consciousness—Timolol—glaucoma	0.000106	0.000285	CcSEcCtD
Mesalazine—CHUK—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.000106	0.000642	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—TXN—glaucoma	0.000105	0.000639	CbGpPWpGaD
Mesalazine—Cough—Timolol—glaucoma	0.000105	0.000283	CcSEcCtD
Mesalazine—CHUK—Apoptosis—TP53—glaucoma	0.000105	0.000638	CbGpPWpGaD
Mesalazine—Decreased appetite—Betaxolol—glaucoma	0.000105	0.000281	CcSEcCtD
Mesalazine—PTGS2—Disease—LRP12—glaucoma	0.000104	0.000632	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—CDKN1B—glaucoma	0.000104	0.000632	CbGpPWpGaD
Mesalazine—Hypertension—Timolol—glaucoma	0.000104	0.00028	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000104	0.000279	CcSEcCtD
Mesalazine—Fatigue—Betaxolol—glaucoma	0.000104	0.000279	CcSEcCtD
Mesalazine—Pain—Betaxolol—glaucoma	0.000103	0.000277	CcSEcCtD
Mesalazine—Constipation—Betaxolol—glaucoma	0.000103	0.000277	CcSEcCtD
Mesalazine—Nausea—Pilocarpine—glaucoma	0.000103	0.000277	CcSEcCtD
Mesalazine—Chest pain—Timolol—glaucoma	0.000103	0.000276	CcSEcCtD
Mesalazine—Arthralgia—Timolol—glaucoma	0.000103	0.000276	CcSEcCtD
Mesalazine—Myalgia—Timolol—glaucoma	0.000103	0.000276	CcSEcCtD
Mesalazine—CHUK—Signaling by SCF-KIT—MMP9—glaucoma	0.000102	0.000622	CbGpPWpGaD
Mesalazine—Anxiety—Timolol—glaucoma	0.000102	0.000275	CcSEcCtD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000102	0.00062	CbGpPWpGaD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000102	0.000274	CcSEcCtD
Mesalazine—Hypersensitivity—Clonidine—glaucoma	0.000102	0.000274	CcSEcCtD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000101	0.000616	CbGpPWpGaD
Mesalazine—Discomfort—Timolol—glaucoma	0.000101	0.000273	CcSEcCtD
Mesalazine—PPARG—Metabolism—CA1—glaucoma	0.000101	0.000614	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000101	0.000612	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—TNF—glaucoma	0.000101	0.00061	CbGpPWpGaD
Mesalazine—Dry mouth—Timolol—glaucoma	0.0001	0.00027	CcSEcCtD
Mesalazine—CHUK—Immune System—TXNIP—glaucoma	0.0001	0.000607	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—CDKN1B—glaucoma	9.95e-05	0.000604	CbGpPWpGaD
Mesalazine—Asthenia—Clonidine—glaucoma	9.93e-05	0.000267	CcSEcCtD
Mesalazine—Feeling abnormal—Betaxolol—glaucoma	9.93e-05	0.000267	CcSEcCtD
Mesalazine—Confusional state—Timolol—glaucoma	9.92e-05	0.000267	CcSEcCtD
Mesalazine—IKBKB—Signaling by NGF—NGF—glaucoma	9.92e-05	0.000602	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	9.92e-05	0.000602	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—CDKN1B—glaucoma	9.9e-05	0.000601	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—CDKN1B—glaucoma	9.85e-05	0.000598	CbGpPWpGaD
Mesalazine—Oedema—Timolol—glaucoma	9.84e-05	0.000264	CcSEcCtD
Mesalazine—Anaphylactic shock—Timolol—glaucoma	9.84e-05	0.000264	CcSEcCtD
Mesalazine—CHUK—Immune System—TBK1—glaucoma	9.82e-05	0.000596	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—CDKN1B—glaucoma	9.8e-05	0.000595	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CTSA—glaucoma	9.8e-05	0.000594	CbGpPWpGaD
Mesalazine—Pruritus—Clonidine—glaucoma	9.79e-05	0.000263	CcSEcCtD
Mesalazine—Infection—Timolol—glaucoma	9.78e-05	0.000263	CcSEcCtD
Mesalazine—Shock—Timolol—glaucoma	9.68e-05	0.00026	CcSEcCtD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	9.66e-05	0.000586	CbGpPWpGaD
Mesalazine—Nervous system disorder—Timolol—glaucoma	9.65e-05	0.000259	CcSEcCtD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.61e-05	0.000583	CbGpPWpGaD
Mesalazine—Urticaria—Betaxolol—glaucoma	9.57e-05	0.000257	CcSEcCtD
Mesalazine—Skin disorder—Timolol—glaucoma	9.56e-05	0.000257	CcSEcCtD
Mesalazine—IKBKB—Apoptosis—TP53—glaucoma	9.54e-05	0.000579	CbGpPWpGaD
Mesalazine—Body temperature increased—Betaxolol—glaucoma	9.52e-05	0.000256	CcSEcCtD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.52e-05	0.000578	CbGpPWpGaD
Mesalazine—Hyperhidrosis—Timolol—glaucoma	9.51e-05	0.000256	CcSEcCtD
Mesalazine—Diarrhoea—Clonidine—glaucoma	9.47e-05	0.000254	CcSEcCtD
Mesalazine—Anorexia—Timolol—glaucoma	9.38e-05	0.000252	CcSEcCtD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—glaucoma	9.26e-05	0.000562	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CA2—glaucoma	9.25e-05	0.000561	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	9.22e-05	0.000559	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—CDKN1B—glaucoma	9.22e-05	0.000559	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—CDKN1B—glaucoma	9.22e-05	0.000559	CbGpPWpGaD
Mesalazine—Hypotension—Timolol—glaucoma	9.2e-05	0.000247	CcSEcCtD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	9.16e-05	0.000556	CbGpPWpGaD
Mesalazine—Dizziness—Clonidine—glaucoma	9.15e-05	0.000246	CcSEcCtD
Mesalazine—CHUK—Signaling by EGFR—CDKN1B—glaucoma	9.14e-05	0.000554	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TXNIP—glaucoma	9.08e-05	0.000551	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—CDKN2B—glaucoma	9.07e-05	0.00055	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—CDKN1B—glaucoma	9.06e-05	0.00055	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.04e-05	0.000549	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.04e-05	0.000549	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—BAD—glaucoma	9.02e-05	0.000547	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—CDKN1B—glaucoma	9.02e-05	0.000547	CbGpPWpGaD
Mesalazine—Musculoskeletal discomfort—Timolol—glaucoma	8.97e-05	0.000241	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—TNF—glaucoma	8.96e-05	0.000544	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—glaucoma	8.95e-05	0.000543	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TBK1—glaucoma	8.9e-05	0.00054	CbGpPWpGaD
Mesalazine—Insomnia—Timolol—glaucoma	8.9e-05	0.000239	CcSEcCtD
Mesalazine—CHUK—Immune System—C1QB—glaucoma	8.88e-05	0.000539	CbGpPWpGaD
Mesalazine—Hypersensitivity—Betaxolol—glaucoma	8.87e-05	0.000239	CcSEcCtD
Mesalazine—Paraesthesia—Timolol—glaucoma	8.84e-05	0.000237	CcSEcCtD
Mesalazine—Vomiting—Clonidine—glaucoma	8.8e-05	0.000236	CcSEcCtD
Mesalazine—Dyspnoea—Timolol—glaucoma	8.77e-05	0.000236	CcSEcCtD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	8.76e-05	0.000531	CbGpPWpGaD
Mesalazine—Somnolence—Timolol—glaucoma	8.75e-05	0.000235	CcSEcCtD
Mesalazine—Rash—Clonidine—glaucoma	8.72e-05	0.000234	CcSEcCtD
Mesalazine—Dermatitis—Clonidine—glaucoma	8.72e-05	0.000234	CcSEcCtD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—VEGFA—glaucoma	8.71e-05	0.000528	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	8.68e-05	0.000526	CbGpPWpGaD
Mesalazine—Headache—Clonidine—glaucoma	8.67e-05	0.000233	CcSEcCtD
Mesalazine—Dyspepsia—Timolol—glaucoma	8.66e-05	0.000233	CcSEcCtD
Mesalazine—Asthenia—Betaxolol—glaucoma	8.64e-05	0.000232	CcSEcCtD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	8.63e-05	0.000524	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	8.58e-05	0.00052	CbGpPWpGaD
Mesalazine—Decreased appetite—Timolol—glaucoma	8.55e-05	0.00023	CcSEcCtD
Mesalazine—CHUK—Signaling Pathways—OPN4—glaucoma	8.54e-05	0.000518	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—CDKN1B—glaucoma	8.54e-05	0.000518	CbGpPWpGaD
Mesalazine—Pruritus—Betaxolol—glaucoma	8.52e-05	0.000229	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Timolol—glaucoma	8.5e-05	0.000228	CcSEcCtD
Mesalazine—Fatigue—Timolol—glaucoma	8.48e-05	0.000228	CcSEcCtD
Mesalazine—Pain—Timolol—glaucoma	8.42e-05	0.000226	CcSEcCtD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	8.36e-05	0.000507	CbGpPWpGaD
Mesalazine—Diarrhoea—Betaxolol—glaucoma	8.24e-05	0.000222	CcSEcCtD
Mesalazine—Nausea—Clonidine—glaucoma	8.22e-05	0.000221	CcSEcCtD
Mesalazine—IKBKB—Signaling by NGF—BAD—glaucoma	8.18e-05	0.000496	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	8.17e-05	0.000496	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GSTT1—glaucoma	8.17e-05	0.000495	CbGpPWpGaD
Mesalazine—Feeling abnormal—Timolol—glaucoma	8.11e-05	0.000218	CcSEcCtD
Mesalazine—IKBKB—Immune System—C1QB—glaucoma	8.05e-05	0.000488	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Timolol—glaucoma	8.05e-05	0.000216	CcSEcCtD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	7.98e-05	0.000484	CbGpPWpGaD
Mesalazine—Dizziness—Betaxolol—glaucoma	7.97e-05	0.000214	CcSEcCtD
Mesalazine—PPARG—Generic Transcription Pathway—NR3C1—glaucoma	7.96e-05	0.000483	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HEYL—glaucoma	7.94e-05	0.000482	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TXN—glaucoma	7.91e-05	0.00048	CbGpPWpGaD
Mesalazine—Urticaria—Timolol—glaucoma	7.82e-05	0.00021	CcSEcCtD
Mesalazine—Body temperature increased—Timolol—glaucoma	7.78e-05	0.000209	CcSEcCtD
Mesalazine—Abdominal pain—Timolol—glaucoma	7.78e-05	0.000209	CcSEcCtD
Mesalazine—IKBKB—Signaling Pathways—OPN4—glaucoma	7.74e-05	0.00047	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—CDKN1B—glaucoma	7.74e-05	0.000469	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTGFR—glaucoma	7.69e-05	0.000467	CbGpPWpGaD
Mesalazine—Vomiting—Betaxolol—glaucoma	7.66e-05	0.000206	CcSEcCtD
Mesalazine—Rash—Betaxolol—glaucoma	7.6e-05	0.000204	CcSEcCtD
Mesalazine—Dermatitis—Betaxolol—glaucoma	7.59e-05	0.000204	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	7.56e-05	0.000458	CbGpPWpGaD
Mesalazine—Headache—Betaxolol—glaucoma	7.55e-05	0.000203	CcSEcCtD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	7.38e-05	0.000448	CbGpPWpGaD
Mesalazine—Hypersensitivity—Timolol—glaucoma	7.25e-05	0.000195	CcSEcCtD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	7.23e-05	0.000439	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	7.22e-05	0.000438	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HEYL—glaucoma	7.2e-05	0.000437	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TXN—glaucoma	7.18e-05	0.000435	CbGpPWpGaD
Mesalazine—Nausea—Betaxolol—glaucoma	7.16e-05	0.000192	CcSEcCtD
Mesalazine—PTGS1—Metabolism—CA1—glaucoma	7.09e-05	0.00043	CbGpPWpGaD
Mesalazine—CHUK—Disease—HDAC9—glaucoma	7.08e-05	0.000429	CbGpPWpGaD
Mesalazine—Asthenia—Timolol—glaucoma	7.06e-05	0.00019	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—MMP9—glaucoma	7e-05	0.000425	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTGFR—glaucoma	6.97e-05	0.000423	CbGpPWpGaD
Mesalazine—Pruritus—Timolol—glaucoma	6.96e-05	0.000187	CcSEcCtD
Mesalazine—PTGS1—Metabolism—CTSA—glaucoma	6.86e-05	0.000416	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	6.81e-05	0.000413	CbGpPWpGaD
Mesalazine—Diarrhoea—Timolol—glaucoma	6.73e-05	0.000181	CcSEcCtD
Mesalazine—PTGS2—Disease—FGFR1OP—glaucoma	6.72e-05	0.000407	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HEYL—glaucoma	6.72e-05	0.000407	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.58e-05	0.000399	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—glaucoma	6.58e-05	0.000399	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—TXN—glaucoma	6.52e-05	0.000395	CbGpPWpGaD
Mesalazine—Dizziness—Timolol—glaucoma	6.51e-05	0.000175	CcSEcCtD
Mesalazine—ALOX5—Metabolism—ABCA1—glaucoma	6.51e-05	0.000395	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CYP1B1—glaucoma	6.51e-05	0.000395	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CA2—glaucoma	6.48e-05	0.000393	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.33e-05	0.000384	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.33e-05	0.000384	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—CDKN1B—glaucoma	6.28e-05	0.000381	CbGpPWpGaD
Mesalazine—Vomiting—Timolol—glaucoma	6.26e-05	0.000168	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—glaucoma	6.21e-05	0.000377	CbGpPWpGaD
Mesalazine—Rash—Timolol—glaucoma	6.2e-05	0.000167	CcSEcCtD
Mesalazine—Dermatitis—Timolol—glaucoma	6.2e-05	0.000167	CcSEcCtD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	6.19e-05	0.000375	CbGpPWpGaD
Mesalazine—Headache—Timolol—glaucoma	6.16e-05	0.000166	CcSEcCtD
Mesalazine—CHUK—Signaling Pathways—RPTOR—glaucoma	6.02e-05	0.000365	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.95e-05	0.000361	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—C3—glaucoma	5.93e-05	0.00036	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.89e-05	0.000357	CbGpPWpGaD
Mesalazine—Nausea—Timolol—glaucoma	5.85e-05	0.000157	CcSEcCtD
Mesalazine—CHUK—Signaling Pathways—NCK2—glaucoma	5.83e-05	0.000354	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—CDKN1B—glaucoma	5.7e-05	0.000346	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—C3—glaucoma	5.7e-05	0.000345	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—BCL2L1—glaucoma	5.68e-05	0.000344	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CA1—glaucoma	5.63e-05	0.000341	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—glaucoma	5.58e-05	0.000338	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—glaucoma	5.48e-05	0.000332	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RPTOR—glaucoma	5.46e-05	0.000331	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.45e-05	0.000331	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CTSA—glaucoma	5.45e-05	0.00033	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—glaucoma	5.39e-05	0.000327	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—C3—glaucoma	5.38e-05	0.000326	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP2—glaucoma	5.33e-05	0.000323	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NCK2—glaucoma	5.28e-05	0.000321	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GSTM1—glaucoma	5.2e-05	0.000315	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—C3—glaucoma	5.16e-05	0.000313	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—BCL2L1—glaucoma	5.15e-05	0.000312	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—BAD—glaucoma	5.15e-05	0.000312	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CA2—glaucoma	5.14e-05	0.000312	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.14e-05	0.000312	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTT1—glaucoma	5.05e-05	0.000307	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.03e-05	0.000305	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.03e-05	0.000305	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HDAC9—glaucoma	4.96e-05	0.000301	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—BAD—glaucoma	4.94e-05	0.0003	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—glaucoma	4.75e-05	0.000288	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—BAD—glaucoma	4.67e-05	0.000283	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—MTHFR—glaucoma	4.6e-05	0.000279	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—TXN—glaucoma	4.57e-05	0.000277	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HDAC9—glaucoma	4.49e-05	0.000273	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—BAD—glaucoma	4.48e-05	0.000272	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—CDKN2B—glaucoma	4.37e-05	0.000265	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—APOE—glaucoma	4.28e-05	0.00026	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.28e-05	0.000259	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CAV1—glaucoma	4.24e-05	0.000257	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HDAC9—glaucoma	4.19e-05	0.000254	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.17e-05	0.000253	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.13e-05	0.00025	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.08e-05	0.000247	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ABCA1—glaucoma	4.03e-05	0.000244	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP1B1—glaucoma	4.03e-05	0.000244	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP9—glaucoma	4e-05	0.000243	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1A—glaucoma	3.93e-05	0.000238	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SMO—glaucoma	3.88e-05	0.000235	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NR3C1—glaucoma	3.83e-05	0.000232	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN2B—glaucoma	3.8e-05	0.000231	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.66e-05	0.000222	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—TXN—glaucoma	3.62e-05	0.00022	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—VEGFA—glaucoma	3.59e-05	0.000218	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CDKN1B—glaucoma	3.58e-05	0.000217	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1A—glaucoma	3.56e-05	0.000216	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NTRK2—glaucoma	3.55e-05	0.000215	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTT1—glaucoma	3.54e-05	0.000215	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SMO—glaucoma	3.52e-05	0.000213	CbGpPWpGaD
Mesalazine—CHUK—Immune System—C3—glaucoma	3.45e-05	0.00021	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDKN1B—glaucoma	3.44e-05	0.000209	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.31e-05	0.000201	CbGpPWpGaD
Mesalazine—CHUK—Immune System—BCL2L1—glaucoma	3.31e-05	0.000201	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.28e-05	0.000199	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CDKN1B—glaucoma	3.25e-05	0.000197	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.23e-05	0.000196	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTM1—glaucoma	3.22e-05	0.000195	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NTRK2—glaucoma	3.22e-05	0.000195	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—NOS3—glaucoma	3.21e-05	0.000194	CbGpPWpGaD
Mesalazine—CHUK—Disease—MTHFR—glaucoma	3.19e-05	0.000193	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—C3—glaucoma	3.13e-05	0.00019	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDKN1B—glaucoma	3.12e-05	0.000189	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—glaucoma	3.08e-05	0.000187	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NGFR—glaucoma	3.04e-05	0.000185	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—BCL2L1—glaucoma	3e-05	0.000182	CbGpPWpGaD
Mesalazine—CHUK—Immune System—BAD—glaucoma	3e-05	0.000182	CbGpPWpGaD
Mesalazine—CHUK—Disease—APOE—glaucoma	2.97e-05	0.00018	CbGpPWpGaD
Mesalazine—CHUK—Disease—CAV1—glaucoma	2.94e-05	0.000178	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—glaucoma	2.93e-05	0.000178	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NTRK1—glaucoma	2.89e-05	0.000175	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.85e-05	0.000173	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MTHFR—glaucoma	2.85e-05	0.000173	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP1B1—glaucoma	2.82e-05	0.000171	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ABCA1—glaucoma	2.82e-05	0.000171	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTT1—glaucoma	2.81e-05	0.00017	CbGpPWpGaD
Mesalazine—CHUK—Disease—BAD—glaucoma	2.77e-05	0.000168	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NGFR—glaucoma	2.76e-05	0.000167	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—BAD—glaucoma	2.72e-05	0.000165	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN2B—glaucoma	2.66e-05	0.000162	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOE—glaucoma	2.65e-05	0.000161	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CAV1—glaucoma	2.62e-05	0.000159	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NTRK1—glaucoma	2.62e-05	0.000159	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EDN1—glaucoma	2.56e-05	0.000155	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN2B—glaucoma	2.42e-05	0.000147	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NGF—glaucoma	2.35e-05	0.000143	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EDN1—glaucoma	2.32e-05	0.000141	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTM1—glaucoma	2.26e-05	0.000137	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN2B—glaucoma	2.25e-05	0.000137	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP1B1—glaucoma	2.24e-05	0.000136	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ABCA1—glaucoma	2.24e-05	0.000136	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—C3—glaucoma	2.23e-05	0.000135	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS3—glaucoma	2.22e-05	0.000135	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NGF—glaucoma	2.13e-05	0.000129	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDKN1B—glaucoma	2.09e-05	0.000127	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOE—glaucoma	2.08e-05	0.000126	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CAV1—glaucoma	2.06e-05	0.000125	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—glaucoma	2.03e-05	0.000123	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—C3—glaucoma	2.03e-05	0.000123	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MTHFR—glaucoma	1.99e-05	0.000121	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NOS3—glaucoma	1.98e-05	0.00012	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FN1—glaucoma	1.96e-05	0.000119	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—BAD—glaucoma	1.94e-05	0.000118	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN1B—glaucoma	1.93e-05	0.000117	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDKN1B—glaucoma	1.89e-05	0.000115	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MTHFR—glaucoma	1.89e-05	0.000115	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOE—glaucoma	1.89e-05	0.000114	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CAV1—glaucoma	1.87e-05	0.000113	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOE—glaucoma	1.86e-05	0.000113	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CAV1—glaucoma	1.84e-05	0.000112	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—glaucoma	1.81e-05	0.00011	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTM1—glaucoma	1.79e-05	0.000109	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FN1—glaucoma	1.78e-05	0.000108	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOE—glaucoma	1.76e-05	0.000107	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—BAD—glaucoma	1.76e-05	0.000107	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CAV1—glaucoma	1.74e-05	0.000106	CbGpPWpGaD
Mesalazine—PTGS2—Disease—BAD—glaucoma	1.64e-05	9.94e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MTHFR—glaucoma	1.58e-05	9.6e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOS3—glaucoma	1.56e-05	9.45e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOE—glaucoma	1.47e-05	8.94e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CAV1—glaucoma	1.46e-05	8.85e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOS3—glaucoma	1.41e-05	8.57e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NOS3—glaucoma	1.39e-05	8.43e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN1B—glaucoma	1.35e-05	8.19e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS3—glaucoma	1.32e-05	7.99e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—glaucoma	1.27e-05	7.71e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—glaucoma	1.25e-05	7.58e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN1B—glaucoma	1.22e-05	7.42e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN1B—glaucoma	1.14e-05	6.92e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—glaucoma	1.13e-05	6.87e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VEGFA—glaucoma	1.12e-05	6.81e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NOS3—glaucoma	1.1e-05	6.69e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VEGFA—glaucoma	1.02e-05	6.17e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—glaucoma	8.48e-06	5.14e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—glaucoma	7.69e-06	4.66e-05	CbGpPWpGaD
